Immune Therapeutics Announces Special Investor Conference

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
133
Immune Therapeutics Announces Special Investor Conference Call to Discuss 2017 Outlook

ORLANDO, Fla., Jan. 27, 2017 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN), a clinical-stage company developing novel therapies for the treatment of immuno-inflammatory diseases and cancer, today announced that it will hold a special investor conference call to discuss the Company’s recent operating highlights and its financial and operational outlook for 2017.  The conference call will follow a press release that will be issued pre-market on January 30, 2017 summarizing these topics.

WHAT: IMUN 2016 Highlights and 2017 Outlook conference call  
 
WHEN: Monday, January 30, 2017 at 11:00 am ET, 8 am PT  
     
WHO: Call and Q&A session will be hosted by Noreen Griffin, Chief Executive Officer,
  and Peter Aronstam, Chief Financial Officer, of Immune Therapeutics, Inc.  
 
HOW: (Toll Free) (866) 682-6100, (International): (862) 255-5401  
 
WEB-CAST:   IMUN Outlook for 2017 Investor Conference Call  

Please call in 10 minutes prior to the conference call to assure you are placed into the call on time.

REPLAY INFO Replay Number (Toll Free): 877-481-4010 Replay Number (International): 919-882-2331 Replay ID: 10214 Teleconference Replay Available Until: Feb 13, 2017 at 11:59 PM

About the Company Immune Therapeutics is a biotechnology company working to combat chronic, life-threatening diseases through the activation and modulation of the body's immune system using its patented immunotherapies with a focus of providing such therapies in emerging nations. Its products and immunotherapy technologies are designed to harness the power of the immune system to improve the treatment of cancer, infections such as HIV/AIDS, chronic inflammatory and autoimmune diseases.

The Company's proprietary technology, therapies and patents include the treatment of a wide range of cancers.  Its most advanced clinical programs involve immunotherapy with met-enkephalin (MENK) (sometimes referred to as opioid growth factor) and its Low Dose Naltrexone product (LDN) or Lodonal TM , which have been shown to stimulate the immune system even in patients with advanced cancer.

Forward Looking Statements

This release may contain forward-looking statements. Actual results may differ from those projected due to a number of risks and uncertainties, including, but not limited to, the possibility that some or all of the matters and transactions considered by the Company may not proceed as contemplated, and by all other matters specified in the Company's filings with the Securities and Exchange Commission. These statements are made based upon current expectations that are subject to risk and uncertainty. The Company does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in the Company's filings with the Securities and Exchange Commission ( www.sec.gov ), including its recent periodic reports. 

Investor/Media Contact: Kevin Yamano Investor Relations Partners Phone: 818-280-6800 kyamano@irpartnersinc.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Jersey Teamsters Stand Firm for Fair Health Worker Deal

Updated Category News Views 117

ImageCare Workers Ready to Strike Normally, when we hear about health care, we're pretending it’s this well-oiled machine. But here we are, witnessing techs and aides at ImageCare gearing up to strike for the first time. Sussex County’s finest have had it up to their ears negotiating for a union contract that doesn’t treat them like an afterthought. Two-Year...

Continue Reading
Tech Job Market Surges with AI and IT Skills Spike

Updated Category News Views 92

Alright, folks, though we're not drowning in champagne just yet, there's a promising uptick in October's tech employment, signaling a rebound or at least some relief for tech pros and market watchers. CompTIA's numbers show a boost of 7,200 jobs in the tech industry while IT occupations expanded by 26,000 slots. That's no small feat when the general job scene elsewhere...

Continue Reading
CorelDRAW's Flexibility: A Designer's One-Time Buy?

Updated Category News Views 66

CorelDRAW: A Design Powerhouse Without Recurring Bills? Every so often, a software option comes along that piques my interest, and right now, it's CorelDRAW Graphics Suite. Consumer365 has shone a light on this nifty tool for its one-time purchase model—a breath of fresh air in the age of endless subscriptions that seem to drain more than enthusiasm as the months roll...

Continue Reading
Rutter Mills Expands Turkey Giveaway to Two Cities

Updated Category News Views 13

An Extra Helping of Community Spirit Rutter Mills is back on the scene again this Thanksgiving, slinging out a thousand turkeys to show their appreciation for the community they’ve called home since 1959. This initiative is the second iteration of their Turkey Drop, an event that's set to become a cherished tradition for years to come. Last year's event only teased the...

Continue Reading
WIC 2026: Global Connectivity and Cyber Futures

Updated Category News Views 144

Connectivity Takes Center Stage in Wuzhen When you throw 1,800 movers and shakers into a room focused on the future of the internet, sparks are gonna fly. That's exactly what's going down at the 2026 World Internet Conference in Wuzhen, China. Brass tacks: this ain't just another snooze-fest. The theme this year screams significance—'Open Source and Openness, Joined...

Continue Reading
VS Pharmtech Enhances Cancer Drug Efficiency, Eyes IPO

Updated Category News Views 86

Revolutionizing Cancer Care, One Dose at a Time Now, here's a twist worth chewing over your morning coffee: VS Pharmtech isn't concocting some newfangled miracle drug but is instead jazzing up the old ones. Their creation, VS-101, isn't just another treatment—it's a radiosensitizer designed to make existing therapies more potent without the toxic baggage. The Science...

Continue Reading
Pre-Owned Jet Inventory Rises; Price Trends Unclear

Updated Category News Views 83

October's Pre-Owned Aircraft Inventory: A Mixed Bag Nothing like leafing through October's data on pre-owned jets and feeling your stomach do that weird flip-flop. Inventory's nudging up, but it's still on its knees compared to last year's numbers. According to Sandhills Global's fresh aviation market reports, we got an increase in what's available on platforms like...

Continue Reading
212NYC Gala Celebrates Ad Industry's Human Touch

Updated Category News Views 98

The Advertising Gala with Heart When you toss nearly 300 advertising honchos into a room at Tribeca's Rooftop, you don't just get another bash; you get an industry checkpoint. This time, the 212NYC shindig on November 5, 2026, wasn't just about stroking egos. It was about spotlighting the soul in business, right when AI threatens to run wild with it. Navigating AI's...

Continue Reading
QORAI CORP's Q4 Nexus: A New AI Frontier

Updated Category News Views 51

Breakthrough in AI: Enter Q4 Nexus It's not every day you see a tech player emerge with something genuinely fresh—QORAI CORP is shaking up the scene with its Q4 Nexus platform. This isn't just another AI model upgrade. We're talking about a rethink of the very architecture we rely on to power these systems. Founder Robby Joshi's brainchild, Q4 Nexus, jazzes up the AI...

Continue Reading
Sass Magazine's 2026 COZY Issue Embraces Intentional Joy

Updated Category News Views 70

An Unexpected Shift in Sass's Seasonal Focus When you think November and December, it's easy to picture the hustle and bustle of holiday preparations—shopping, parties, running around. But toss all that hullabaloo out the window, because Sass Magazine has thrown a curveball for their 2026 release. They're steering the ship towards the calm, with their COZY Issue shaping...

Continue Reading

Top 5 Most Recently Viewed Articles

Crypto ETFs Make Waves: Dogecoin and XRP Soar in Trading

Updated Category News Views 209

Exciting Developments in Cryptocurrency ETFs In a remarkable turn of events for the cryptocurrency market, Dogecoin (DOGE) and XRP are experiencing a surge as they mark groundbreaking trading volumes on the launch day of their respective exchange-traded funds (ETFs). This uptick comes on the heels of the SEC's announcement regarding enhanced listing standards for...

Continue Reading
Ashling's New Feat: Microsoft Recognition in AI

Updated Category News Views 159

Microsoft's Stamp of Approval for Ashling Ah, recognition—it's not just for egos. When Ashling, an AI consultancy heavyweight, gets a nod from Microsoft, it's worth more than a footnote in the company newsletter. This isn't some participation trophy. Nope, it's a badge saying they know their Data & AI, and Digital & App Innovation inside out. On October 29, 2026,...

Continue Reading
Zoom Communications Exceeds Expectations with FY2025 Report

Updated Category News Views 933

Zoom's Impressive Year-End Financial Report Zoom Communications, Inc. (NASDAQ: ZM) recently published its financial results for the fourth quarter and the entirety of fiscal year 2025, reflecting substantial growth and innovation. With a total revenue of $1,184.1 million for the fourth quarter, this marks a year-over-year increase of 3.3%. When evaluated in constant...

Continue Reading
Investors Alert: Key Class Action Deadlines Upcoming

Updated Category News Views 230

Class Action Lawsuits Overview Investors, pay close attention! Class action lawsuits are now underway for several publicly-traded companies, and shareholder involvement is crucial. One such entity actively pursuing these cases is The Law Offices of Frank R. Cruz, reminding affected shareholders of their rights. Time is of the essence, as there are strict deadlines for...

Continue Reading
Fermi Inc. (FRMI) Faces Significant Setback with Tenant News

Updated Category News Views 182

Fermi Inc. Shares Decline Significantly Following Contract Issues On a recent day, investors of Fermi Inc. (NASDAQ: FRMI) experienced a notable drop in share prices, with a staggering decline of about 33%. This drop followed the announcement regarding the termination of an essential contract with a prospective anchor tenant, known as the First Tenant, for Fermi's...

Continue Reading